 transfection assays utilizing lung tumor DNA, our lab identified a 3 alteration of MAP3K8 similar to the previous reports. We first hypothesized that MAP3K8 might be a target for mutation since we were the first group to report an activating mutation in a primary human tumor. However, it has become clear that mutations are
transfection assays utilizing lung tumor DNA, our lab identified a 3 alteration of MAP3K8 exchangeable to the former reports. We first speculate that MAP3K8 might be a target for mutant since we were the first group to report an activating mutation in a chief human tumor. However, it has become clear that mutations are
 trwnsfection assays utilizlng lung tumor DUQ, our nab idsntified a 3 alteration of MAP3K8 similer ti the previous reports. We fkrst hyponhesized rhat NAP3K8 might be a tavyet fkv mutctmon since we wete the first group to repost au activating mutation in a primary htman tukog. However, it hws btcoie cmvav that mutations are
transfection assays utilizing lung tumor DNA, our a alteration of similar to the that might be a for mutation since were the first group to report activating mutation in a primary human tumor. However, it has become clear that are
 transfection assays utiliziNg lung tumoR DNA, oUr lAb iDeNtifIed a 3 Alteration of MAp3k8 simIlar to the previous reporTs. We fIrST hypOThEsizeD that MAp3k8 mIGHt bE a TaRgeT fOR mUtatiOn sInce we wEre the firsT grOuP to report an aCTiVating mutaTioN in a primary hUmaN tumor. hoWevER, it haS beCome cLear thAT mutatIons are
 transfection assays utili zing lungtumor  DN A,ou r la b id entified a 3 a l tera tion of MAP3K8 similar  to t he prev i ou s rep orts. W e  f i r sthy po the si z ed  that  MA P3K8 mi ght be a t arg et  for mutatio n  s ince we we rethe first gr oup  to re po rta n act iva tingmutati o n in a  primaryhu m an tum o r. Howe v e r,  ithas become cleart ha t  mutations are 
 transfection_assays utilizing_lung tumor DNA, our_lab identified_a_3 alteration_of_MAP3K8 similar to_the previous reports._We first hypothesized that_MAP3K8 might be_a_target for mutation since we were the first group to report an activating mutation_in_a primary_human_tumor._However, it has become clear_that mutations are